• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两种四氯化碳诱导大鼠肝硬化模型方案的比较——提高产量和重现性。

Comparison of Two Protocols of Carbon Tetrachloride-Induced Cirrhosis in Rats - Improving Yield and Reproducibility.

机构信息

Servicio de Aparato Digestivo, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

出版信息

Sci Rep. 2018 Jun 15;8(1):9163. doi: 10.1038/s41598-018-27427-9.

DOI:10.1038/s41598-018-27427-9
PMID:29907790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6003930/
Abstract

Despite being a cardinal experimental model, the induction of cirrhosis in rats by repeated exposure to carbon tetrachloride (CCl4) has low reproducibility. Here, we compared two models of cirrhosis induced by orogastric administration of CCl4 once (CCl4-1xWk) or twice a week (CCl4-2xWk) for 12 weeks in male Sprague-Dawley rats. Control rats received water instead of CCl4. Both CCl4 protocols similarly attenuated body weight gain (p < 0.01 vs. Control). Although both CCl4 protocols increased hepatic fibrosis, portal hypertension and splenomegaly, the magnitude of these alterations was higher and more consistent in CCl4-2xWk rats. Importantly, two CCl4-1xWk rats did not develop cirrhosis versus a 100% yield of cirrhosis in CCl4-2xWk rats. The CCl4-2xWk protocol consistently induced liver atrophy together with hematological, biochemical and coagulation abnormalities characteristic of advanced cirrhosis that were absent in CCl4-1xWk rats. Ascites occurred in 20% and 80% of rats in theCCl4-1xWk and CCl4-2xWk groups (p < 0.01). All rats showed normal renal function, arterial blood gases and stable systemic hemodynamics. The total dose of CCl4 and mortality rate were similar in both protocols. The CCl4-2xWk protocol, therefore, was highly reproducible and effective for the induction of experimental cirrhosis within a confined time, representing a valuable advance for liver research.

摘要

尽管大鼠重复暴露于四氯化碳(CCl4)可诱导肝硬化,但这种方法的可重复性较低。在这里,我们比较了两种通过口胃管给予 CCl4 诱导肝硬化的模型,一种是每周一次(CCl4-1xWk),另一种是每周两次(CCl4-2xWk),共 12 周。对照组大鼠给予水而不是 CCl4。两种 CCl4 方案均显著降低了大鼠体重(与对照组相比,p<0.01)。虽然两种 CCl4 方案均增加了肝纤维化、门静脉高压和脾肿大,但 CCl4-2xWk 大鼠的这些改变程度更高且更一致。重要的是,与 CCl4-2xWk 组 100%发生肝硬化的大鼠相比,两组 CCl4-1xWk 大鼠中有两例未发展为肝硬化。CCl4-2xWk 方案始终诱导肝萎缩,同时伴有肝硬化的血液学、生化和凝血异常,而这些异常在 CCl4-1xWk 大鼠中并不存在。CCl4-1xWk 和 CCl4-2xWk 组分别有 20%和 80%的大鼠发生腹水(p<0.01)。两组大鼠的肾功能、动脉血气和稳定的全身血流动力学均正常。两种方案的 CCl4 总剂量和死亡率相似。因此,CCl4-2xWk 方案在有限的时间内可高度重现并有效地诱导实验性肝硬化,这是肝研究的一个有价值的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/f074848255e2/41598_2018_27427_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/1ca12b77c41a/41598_2018_27427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/8fc0b447b284/41598_2018_27427_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/110a8aec7594/41598_2018_27427_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/fc255889091c/41598_2018_27427_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/cb7000e0f68a/41598_2018_27427_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/f074848255e2/41598_2018_27427_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/1ca12b77c41a/41598_2018_27427_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/8fc0b447b284/41598_2018_27427_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/110a8aec7594/41598_2018_27427_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/fc255889091c/41598_2018_27427_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/cb7000e0f68a/41598_2018_27427_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec56/6003930/f074848255e2/41598_2018_27427_Fig6_HTML.jpg

相似文献

1
Comparison of Two Protocols of Carbon Tetrachloride-Induced Cirrhosis in Rats - Improving Yield and Reproducibility.两种四氯化碳诱导大鼠肝硬化模型方案的比较——提高产量和重现性。
Sci Rep. 2018 Jun 15;8(1):9163. doi: 10.1038/s41598-018-27427-9.
2
Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.依诺肝素不能改善晚期肝硬化大鼠的肝纤维化或门静脉高压。
Liver Int. 2018 Jan;38(1):102-112. doi: 10.1111/liv.13510. Epub 2017 Sep 30.
3
An endothelin receptor antagonist TAK-044 ameliorates carbon tetrachloride-induced acute liver injury and portal hypertension in rats.内皮素受体拮抗剂TAK-044可改善四氯化碳诱导的大鼠急性肝损伤和门静脉高压。
Liver. 1998 Feb;18(1):39-48. doi: 10.1111/j.1600-0676.1998.tb00125.x.
4
Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride.
Hepatology. 1986 Jul-Aug;6(4):694-700. doi: 10.1002/hep.1840060426.
5
[The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].齐墩果酸对四氯化碳诱导的肝硬化大鼠的抗门脉高压作用
Zhong Yao Cai. 2012 Jun;35(6):930-5.
6
Connective tissue growth factor in hepatocytes is elevated by carbon tetrachloride via STAT3 activation.四氯化碳通过 STAT3 激活使肝细胞中结缔组织生长因子升高。
Mol Med Rep. 2020 Mar;21(3):1390-1398. doi: 10.3892/mmr.2020.10916. Epub 2020 Jan 8.
7
[Chronic arsenic poisoning and idiopathic portal hypertension: report of a case].[慢性砷中毒与特发性门静脉高压症:一例报告]
Zhonghua Bing Li Xue Za Zhi. 2012 Jul;41(7):487-8. doi: 10.3760/cma.j.issn.0529-5807.2012.07.015.
8
Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.用反式-4-(对甲苯磺酰基)环己基异氰酸酯抑制可溶性环氧化物水解酶可减轻四氯化碳诱导的大鼠肝硬化中的肝纤维化和门静脉压力。
Clin Res Hepatol Gastroenterol. 2018 Apr;42(2):118-125. doi: 10.1016/j.clinre.2017.09.001. Epub 2017 Oct 12.
9
Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.Janus 激酶-2 与门静脉高压以及啮齿动物和人类肝硬化的并发症直接相关。
Gut. 2017 Jan;66(1):145-155. doi: 10.1136/gutjnl-2015-309600. Epub 2015 Sep 17.
10
Cryopreserved fetal liver cell transplants support the chronic failing liver in rats with CCl4-induced cirrhosis.冷冻保存的胎肝细胞移植可支持四氯化碳诱导肝硬化大鼠的慢性衰竭肝脏。
Cell Transplant. 2006;15(1):23-33. doi: 10.3727/000000006783982232.

引用本文的文献

1
Mesenchymal Stem Cells Loaded in Injectable Alginate Hydrogels Promote Liver Growth and Attenuate Liver Fibrosis in Cirrhotic Rats.负载于可注射藻酸盐水凝胶中的间充质干细胞促进肝硬化大鼠肝脏生长并减轻肝纤维化
Gels. 2025 Mar 27;11(4):250. doi: 10.3390/gels11040250.
2
Direct-acting antivirals sofosbuvir and daclatasvir attenuate carbon tetrachloride-induced liver fibrosis in mice.直接作用抗病毒药物索磷布韦和达卡他韦可减轻四氯化碳诱导的小鼠肝纤维化。
Liver Res. 2023 Feb 9;7(1):71-81. doi: 10.1016/j.livres.2023.02.001. eCollection 2023 Mar.
3
New insight on the acute CCl-induced hepatotoxicity model in rats.

本文引用的文献

1
Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.依诺肝素不能改善晚期肝硬化大鼠的肝纤维化或门静脉高压。
Liver Int. 2018 Jan;38(1):102-112. doi: 10.1111/liv.13510. Epub 2017 Sep 30.
2
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.二甲双胍可降低肝硬化大鼠的肝内阻力和门静脉压力。
Am J Physiol Gastrointest Liver Physiol. 2015 Sep 1;309(5):G301-9. doi: 10.1152/ajpgi.00010.2015. Epub 2015 Jul 2.
3
Animal models of chronic liver diseases.慢性肝脏疾病的动物模型。
对大鼠急性四氯化碳诱导的肝毒性模型的新见解。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):7643-7648. doi: 10.1007/s00210-025-03824-6. Epub 2025 Jan 29.
4
In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration.用于药效学评价和病理学探索的肝纤维化体内和体外模型
Int J Mol Sci. 2025 Jan 15;26(2):696. doi: 10.3390/ijms26020696.
5
Targeted animal models for preclinical assessment of cellular and gene therapies in pancreatic and liver diseases: regulatory and practical insights.用于胰腺和肝脏疾病细胞及基因治疗临床前评估的靶向动物模型:监管与实践见解
Cytotherapy. 2025 Mar;27(3):259-278. doi: 10.1016/j.jcyt.2024.11.008. Epub 2024 Nov 19.
6
Resveratrol treatment ameliorates hepatic damage via the TGF-β/SMAD signaling pathway in a phenobarbital/CCl-induced hepatic fibrosis model.在苯巴比妥/四氯化碳诱导的肝纤维化模型中,白藜芦醇治疗通过TGF-β/SMAD信号通路改善肝损伤。
Iran J Basic Med Sci. 2024;27(9):1124-1133. doi: 10.22038/IJBMS.2024.75737.16398.
7
Label-free proteomic analysis reveals the hepatoprotective mechanism of gypenosides in liver injury rats.无标记蛋白质组学分析揭示了绞股蓝总皂苷对肝损伤大鼠的保肝机制。
Front Pharmacol. 2024 Jun 27;15:1417575. doi: 10.3389/fphar.2024.1417575. eCollection 2024.
8
Effect of high-dose intravenous iron injection on hepatic function in a rat model of cirrhosis.大剂量静脉铁注射对肝硬化大鼠肝功能的影响。
J Int Med Res. 2024 May;52(5):3000605241253733. doi: 10.1177/03000605241253733.
9
Novel drug therapy of acute hepatic failure induced in rats by a combination of tadalafil and Lepidium sativum.他达拉非联合刺山柑治疗大鼠急性肝衰竭的新药疗法。
BMC Complement Med Ther. 2024 Feb 27;24(1):104. doi: 10.1186/s12906-024-04406-4.
10
Shizao decoction for cirrhotic ascites: assessing potential targets based on network analysis combined with pharmacokinetics and metabolomics.实枣汤治疗肝硬化腹水:基于网络分析结合药代动力学和代谢组学评估潜在靶点
Front Pharmacol. 2024 Jan 23;15:1298818. doi: 10.3389/fphar.2024.1298818. eCollection 2024.
Am J Physiol Gastrointest Liver Physiol. 2013 Mar 1;304(5):G449-68. doi: 10.1152/ajpgi.00199.2012. Epub 2012 Dec 28.
4
12th Report on Carcinogens.第十二份致癌物报告。
Rep Carcinog. 2011;12.
5
Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis.肝脏在预腹水性肝硬化大鼠全身炎症诱导中的关键作用。
Hepatology. 2010 Dec;52(6):2086-95. doi: 10.1002/hep.23961.
6
Restrictive model of compensated carbon tetrachloride-induced cirrhosis in rats.大鼠四氯化碳诱导的代偿性肝硬化的限制性模型
World J Gastroenterol. 2008 Dec 7;14(45):6943-7. doi: 10.3748/wjg.14.6943.
7
Rating of CCl(4)-induced rat liver fibrosis by blood serum glycomics.通过血清糖组学对四氯化碳诱导的大鼠肝纤维化进行评级
J Gastroenterol Hepatol. 2007 Jul;22(7):1148-54. doi: 10.1111/j.1440-1746.2006.04553.x.
8
Effect of the administration of fermentable and non-fermentable dietary fibre on intestinal bacterial translocation in ascitic cirrhotic rats.
Clin Nutr. 2007 Jun;26(3):383-7. doi: 10.1016/j.clnu.2007.01.008. Epub 2007 Mar 26.
9
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.肝纤维化模型:探索实体器官中炎症与修复的动态本质
J Clin Invest. 2007 Mar;117(3):539-48. doi: 10.1172/JCI30542.
10
Animal models of portal hypertension.门静脉高压症的动物模型。
World J Gastroenterol. 2006 Nov 7;12(41):6577-84. doi: 10.3748/wjg.v12.i41.6577.